Abstract 184: Clinical Outcomes According to Previous Intracranial Hemorrhage in Patients Receiving Intravenous Thrombolysis
Objective: This study aimed to describe clinical outcomes in patients treated with intravenous (IV) tPA according to evidence of previous Intracranial hemorrhage (ICH) and investigate the associations between previous ICH and clinical outcomes.
Methods: Using a prospective multicenter stroke registry database, we identified acute ischemic stroke patients who were hospitalized to the 14 participating centers between January 2011 and July 2013 and were treated with IV tPA within 4.5 h of onset. Presence of previous ICH was screened using the formal radiologic reports or the clinical history of ICH from the registry database. If suspected, previous ICH was confirmed through direct review of brain MRI. As clinical outcomes, modified Rankin scale (mRS) 0-1 at discharge, mortality during hospitalization and symptomatic hemorrhagic transformation (sHT) were collected. sHT was defined according to the definition of SITS-MOST trial.
Results: Among 1495 patients who were treated with IV tPA, 70 (4.7%) had evidence of previous ICH. sHT developed in 69 (4.6%) of all subjects; 7.1% (n=5) of 70 patients with previous ICH and 4.5% (n=64) of 1425 without previous ICH (p=0.25 on Fisher’s exact test). Hospital Mortality and mRS 0-1 at discharge was observed in 5.6% and 26.6% of all subjects and in 8.6% and 22.9% of those with previous ICH and 5.4% and 26.7% in those without it (p=0.28 on Fisher’s exact test and p=0.47 on Pearson’s chi-squared test, respectively). Multivariable logistic regression analysis with adjustment for age, initial National Institute of Health Stroke Scale, initial glucose and tPA dose showed that previous ICH was not associated with sHT, mortality during hospitalization and having discharge mRS 0-1 (p’s >0.4). Review of MRI on 5 patients who had previous ICH and developed sHT after IV tPA demonstrated that, in 4 cases, location of sHT was different from where previous ICH had developed, but in 1 case sHT occurred exactly where previous ICH had developed.
Conclusions: This study shows that previous ICH may not increase the risk of sHT and death and aggravate functional outcome at discharge. However, it should be noted that the retrospective nature and small sample size of this study limit the generalization of its results.
Author Disclosures: S. Lee: None. T. Park: None. S. Park: None. S. Lee: None. Y. Ko: None. K. Lee: None. J. Lee: None. J. Park: None. K. Kang: None. J. Choi: None. D. Kim: None. W. Ryu: None. J. Kim: None. K. Choi: None. J. Cha: None. D. Kim: None. B. Lee: None. K. Yu: None. M. Oh: None. Y. Cho: None. K. Hong: None. W. Kim: None. J. Lee: None. J. Lee: None. D. Shin: None. M. Yeo: None. B. Kim: None. M. Han: None. H. Bae: None.
- © 2015 by American Heart Association, Inc.